Japan tech group's latest transformation faced with declining profitability

Fujifilm's bio-CDMO business is involved in contract manufacturing of biomedical products. (Photo by Kohei Yamada)
HIDEAKI HIGASHIURA
October 14, 2026 05:40 JST
TOKYO -- Japanese technology group Fujifilm Holding is facing questions over whether its 1 trillion yen ($6.31 billion) bet on the biomedical business will pay off.
